EUH Dressler Case Conference: Review of cardiac sarcoidosis

Bottom Line: Increased awareness and diagnostic techniques are the primary reasons for the exponential increase in the prevalence of cardiac sarcoidosis during the last decade. More evidence is needed to determine optimal management. First-line treatment is corticosteroids; authors recommend also using immunosuppressive therapy. For either primary or secondary prevention of ventricular arrhythmias and cardiac death, implantable-cardioverter defibrillators (ICDs) should be a consideration for all patients.

Reference: Young L, Sperry BW, Hachamovitch R. Update on treatment in cardiac sarcoidosisCurr Treat Options Cardiovasc Med. 2017 Jun.


About Lisa

I have been a Clinical Informationist (aka Medical Librarian) for Emory University since September 2013. Prior to that, I was a Medical Librarian for Lincoln Memorial University (LMU) from March 2007 to August 2013 and served its DeBusk College of Osteopathic Medicine, Caylor School of Nursing, and allied health programs. From January 2002 - March 2007, I served the Medical Assisting (MA), Occupational Therapy Assistant, Physical Therapy Assistant, Radiologic Technologist, and Nursing programs at South College in Knoxville, Tennessee. I graduated from The University of Tennessee School of Information Sciences with a Master of Science degree in December 2000.
This entry was posted in Background question, EUH, Therapy and tagged . Bookmark the permalink.